EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms

Israel Vlodavsky iD, Maram Hilwi, Yasmin Kayal, Soaad Soboh, Neta Ilan iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202400286r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2024. Verfasst von Israel Vlodavsky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel. Hauptthemen laut MEDLINE: Inflammation, Neoplasms, Glucuronidase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation, Israel Cancer Research Fund (ICRF), US-Israel Binational Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HPSE2 , the gene‐encoding heparanase 2 (Hpa2), is mutated in urofacial syndrome (UFS), a rare autosomal recessive congenital disease attributed to peripheral neuropathy. Hpa2 lacks intrinsic heparan sulfate (HS)‐degrading activity, the hallmark of heparanase (Hpa1), yet it exhibits a high affinity toward HS, thereby inhibiting Hpa1 enzymatic activity. Hpa2 regulates selected genes that promote normal differentiation, tissue homeostasis, and endoplasmic reticulum (ER) stress, resulting in antitumor, antiangiogenic, and anti‐inflammatory effects. Importantly, stress conditions induce the expression of Hpa2, thus establishing a feedback loop, where Hpa2 enhances ER stress which, in turn, induces Hpa2 expression. In most cases, cancer patients who retain high levels of Hpa2 survive longer than patients bearing Hpa2‐low tumors. Experimentally, overexpression of Hpa2 attenuates the growth of tumor xenografts, whereas Hpa2 gene silencing results in aggressive tumors. Studies applying conditional Hpa2 knockout (cHpa2‐KO) mice revealed an essential involvement of Hpa2 contributed by the host in protecting against cancer and inflammation. This was best reflected by the distorted morphology of the Hpa2‐null pancreas, including massive infiltration of immune cells, acinar to adipocyte trans‐differentiation, and acinar to ductal metaplasia. Moreover, orthotopic inoculation of pancreatic ductal adenocarcinoma (PDAC) cells into the pancreas of Hpa2‐null vs. wild‐type mice yielded tumors that were by far more aggressive. Likewise, intravenous inoculation of cancer cells into cHpa2‐KO mice resulted in a dramatically increased lung colonization reflecting the involvement of Hpa2 in restricting the formation of a premetastatic niche. Elucidating Hpa2 structure–activity‐relationships is expected to support the development of Hpa2‐based therapies against cancer and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationNeoplasmsGlucuronidaseHumansAnimalsMiceEndoplasmic Reticulum Stress

Stichwörter der Autor:innen

ER stressheparanaseheparanase‐2inflammationmetastatic nichepancreatic cancerprotective effectstissue homeostasistumor microenvironmenttumor suppressor

Substanzen

Glucuronidase

Autor:innen und Institutionen

  • Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel.

ORCID-Profile: Israel Vlodavsky, Neta Ilan

Förderung

  • Israel Science Foundation
  • Israel Cancer Research Fund (ICRF)
  • US-Israel Binational Science Foundation
  • Israel Cancer Association (ICA)

Zitieren

APA

Vlodavsky, I., Hilwi, M., Kayal, Y., Soboh, S., & Ilan, N. (2024). Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms. The FASEB Journal. https://doi.org/10.1096/fj.202400286r

Vancouver

Vlodavsky I, Hilwi M, Kayal Y, Soboh S, Ilan N. Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms. The FASEB Journal. 2024. doi:10.1096/fj.202400286r

BibTeX
@article{Vlodavsky2024,
  author = {Vlodavsky, Israel and Hilwi, Maram and Kayal, Yasmin and Soboh, Soaad and Ilan, Neta},
  title = {Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202400286r}
}
Kostenlos starten →